Prollenium US, Inc. vs. Allergan Industrie, SAS
Explore the PTAB proceeding IPR2019-01509 filed by Prollenium US, Inc. on 2019-09-03. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2019-01509
Filing Date
2019-09-03
Accorded Filing Date
2019-09-03
Institution Decision Date
2020-03-19
Last Modified Date
2021-02-19
Proceeding Type
IPR
Termination Date
2021-02-19
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Prollenium US, Inc.
Represented By
Christopher CurfmanPatent Owner / Respondent
Allergan Industrie, SAS
Represented By
Anthony M. InsognaPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 36373 | Allan Brookes | +1 508-733-3757 |
| 44075 | Portia Chen | +1 847-937-8272 |
| 44554 | Matthew Brady | +1 714-246-4788 |
| 46652 | Stephen D'Amico | +1 224-440-7242 |
| 46789 | Mark Hyman | +1 847-937-8941 |
| 47413 | Eric Baude | +1 847-938-8389 |
| 47717 | Renee Kosslak | +1 650-454-2338 |
| 48591 | Tara Seshadri | +1 508-688-8058 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 9,358,322 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,328,180 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,391,202 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,173,232 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2022031387 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,595,608 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,793,408 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,627,808 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,450,475 B2 | US Continuation / Sibling | View Official Patent → |
Prollenium US Inc. et al. v. Allergan Industrie, SAS et al.
Prollenium US, Inc. v. Allergan Industrie, SAS
TEOXANE S.A. v. Allergan, plc et al.
Galderma S.A. et al. v. Allergan Industrie, SAS et al.
Allergan USA, Inc. v. Prollenium US Inc.